Literature DB >> 23023935

microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.

Xu-Chao Zhu1, Qiong-Zhu Dong, Xiao-Fei Zhang, Biao Deng, Hu-Liang Jia, Qin-Hai Ye, Lun-Xiu Qin, Xing-Zhong Wu.   

Abstract

In the present study, we constructed a lentivirus vector encoding the miR-29a precursor and established two stably infected cell lines, PLC-29a and 97L-29a. The overexpression of miR-29a was confirmed by TaqMan RT-PCR and significantly suppressed the growth of the hepatocellular carcinoma cell lines MHCC-97L and PLC. Dual-luciferase reporter assays indicated that the SPARC mRNA 3'UTR was directly targeted by miR-29a since the mutated 3'UTR was not affected. Silencing SPARC expression by RNAi knockdown resulted in a similar effect as miR-29a overexpression on hepatocellular carcinoma (HCC) cell growth regulation. Anti-miR-29a oligonucleotides (AMOs) upregulated the levels of SPARC in the HCC cells. The phosphorylation of AKT/mTOR downstream of SPARC was inhibited in miR-29a-overexpressing HCC cells. We further examined and compared the expression levels of miR-29a in HCC tissues and the corresponding nearby non-cancerous liver tissues of 110 patients with HCC by qRT-PCR, and significantly lower expression of miR-29a was observed in the tissues affected by HCC. Our findings demonstrate that the expression of miR-29a is important in the regulation of the SPARC-AKT pathway and HCC growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023935     DOI: 10.3892/ijmm.2012.1140

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  32 in total

1.  MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.

Authors:  Fei Zhang; Wei Huang; Meixia Sheng; Tielong Liu
Journal:  Tumour Biol       Date:  2014-11-13

2.  MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase.

Authors:  Yifei Zhang; Mohammed Ghazwani; Jiang Li; Ming Sun; Donna B Stolz; Fengtian He; Jie Fan; Wen Xie; Song Li
Journal:  Biochem Biophys Res Commun       Date:  2014-03-17       Impact factor: 3.575

3.  Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma.

Authors:  Hong-Wei Hua; Feng Jiang; Qian Huang; Zhi-Jun Liao; Gang Ding
Journal:  Tumour Biol       Date:  2014-09-25

4.  MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.

Authors:  Yongqiang Li; Zhi Wang; Yijiang Li; Ruijun Jing
Journal:  Oncol Lett       Date:  2017-03-22       Impact factor: 2.967

Review 5.  MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.

Authors:  Iván Lyra-González; Laura E Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  World J Hepatol       Date:  2015-06-18

Review 6.  The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Authors:  Catalina Atorrasagasti; Agostina M Onorato; Guillermo Mazzolini
Journal:  J Physiol Biochem       Date:  2022-08-26       Impact factor: 5.080

7.  Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.

Authors:  D D H Tran; C Kessler; S E Niehus; M Mahnkopf; A Koch; T Tamura
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

8.  SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.

Authors:  Houda Alachkar; Ramasamy Santhanam; Kati Maharry; Klaus H Metzeler; Xiaomeng Huang; Jessica Kohlschmidt; Jason H Mendler; Juliana M Benito; Christopher Hickey; Paolo Neviani; Adrienne M Dorrance; Mirela Anghelina; Jihane Khalife; Somayeh S Tarighat; Stefano Volinia; Susan P Whitman; Peter Paschka; Pia Hoellerbauer; Yue-Zhong Wu; Lina Han; Brad N Bolon; William Blum; Krzysztof Mrózek; Andrew J Carroll; Danilo Perrotti; Michael Andreeff; Michael A Caligiuri; Marina Konopleva; Ramiro Garzon; Clara D Bloomfield; Guido Marcucci
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 9.  MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

Authors:  Jie Sun; Haiqi Lu; Xian Wang; Hongchuan Jin
Journal:  ScientificWorldJournal       Date:  2013-02-04

10.  miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.

Authors:  Feifei Qiu; Rui Sun; Ning Deng; Tianyu Guo; Yange Cao; Ying Yu; Xuejun Wang; Bingcheng Zou; Songmei Zhang; Tao Jing; Tao Ling; Jun Xie; Qing Zhang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.